Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 97

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 97
---
 additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations,
or other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams,
research programs or product candidates or grant licenses on terms that may not be favorable to us and/or may reduce the value of our
common stock. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit,
reduce or terminate our product development or future commercialization efforts or grant rights to develop and market our product candidates
even if we would otherwise prefer to develop and market such product candidates ourselves.

As such, we have concluded that such plans do
not alleviate the substantial doubt about our ability to continue as a going concern for one year from the date the accompanying financial
statements are issued.

The accompanying financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business, and
do not include any adjustments to the amount and classification of assets and liabilities that may be necessary should we be unable to
continue as a going concern.

53

Contractual Obligations

The following table summarizes our contractual obligations as of December
31, 2024:

    Payments Due By Period 

    Total  
    Less than 
    1 year  
    1-3 years  
    4-5 years  
    More than
    5 Years 
  
    Principal obligations on the debt arrangements 
    $150,000  
    $-  
    $3,621  
    $6,799  
    $139,580 
  
    Interest obligations on the debt arrangements 
     104,797  
     8,772  
     13,923  
     10,746  
     71,356 
  
    Accounts payable and accrued expenses 
     1,007,618  
     1,007,618  
     -  
     -  
     - 
  
    Total 
    $1,262,415  
    $1,016,390  
    $17,544  
    $17,545  
    $210,936 

Amounts related to contingent milestone payments
are not considered contractual obligations as they are contingent on the achievement of certain milestones. These contingent milestones
may or may not be achieved. We